Micron Technology, Inc. (NASDAQ:MU) (MarketWatch) Micron Technology Inc. MU, +10.22% shares surged Monday after one analyst nearly doubled his price target...
Keep Reading →
March 12 - Market Movers, News - Comments
Anthera Pharmaceuticals Inc (NASDAQ:ANTH): Hal Mintz’s Sabby Capital filed an amended 13D. You can check out Sabby Capital’s latest holdings...
Keep Reading →
January 9 - Hedge Funds - Comments
Anthera Pharmaceuticals Inc (NASDAQ:ANTH) is heading into the close of the year more than 60% down on its early week market cap, on the release of some...
Keep Reading →
December 28 - News, Stock Analysis - Comments
The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines. Of...
Keep Reading →
December 16 - Hedge Funds, News - Comments
Another day done in biotech, and we’re fast closing in on the end of the week. Just as was the case early last month, political influence is being exerted...
Keep Reading →
December 8 - Market Movers, News, Stock Analysis - Comments
While the wider biotech space was enjoying something of a unexpected return to positive sentiment on Wednesday and Thursday, buoyed by the lifting of...
Keep Reading →
November 11 - News, Stock Analysis - Comments
It’s going to be a busy quarter for a few companies in the biotech space, with a number of catalysts slated for the next month or so. Presentation season...
Keep Reading →
October 26 - News, Stock Analysis - Comments
Mark Lampert‘s Biotechnology Value Fund recently filed a Form 13G with the SEC, in which it reported acquiring 4.58 million shares of Anthera Pharmaceuticals...
Keep Reading →
September 19 - Hedge Funds, News - Comments
Unilife Corp (NASDAQ:UNIS) and Anthera Pharmaceuticals Inc (NASDAQ:ANTH) were among the stocks losing ground early this morning, though one of them has...
Keep Reading →
September 15 - Hedge Funds, News - Comments
In an effort to generate funds for clinical research and development and other general corporate purposes, Anthera Pharmaceuticals Inc (NASDAQ:ANTH) ...
Keep Reading →
July 9 - Hedge Funds, News - Comments
Last Friday, Kevin Kotler’s Broadfin Capital disclosed a marked increase (of almost 70%) in its exposure to Anthera Pharmaceuticals Inc (NASDAQ:ANTH...
Keep Reading →
October 6 - Hedge Funds, News - Comments
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio. One of the companies involved...
Keep Reading →
January 16 - Hedge Funds, News - Comments
